These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10321360)

  • 1. Money, politics, and medicine: the American Medical PAC's strategy of giving in U.S. house races.
    Wilkerson JD; Carrell D
    J Health Polit Policy Law; 1999 Apr; 24(2):335-55. PubMed ID: 10321360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campaign contributions from the American Medical Political Action Committee to Members of Congress. For or against the public health?
    Sharfstein JM; Sharfstein SS
    N Engl J Med; 1994 Jan; 330(1):32-7. PubMed ID: 8018142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The American Medical Political Action Committee: which senators get the money and why?
    Gutermuth K
    J Health Polit Policy Law; 1999 Apr; 24(2):357-82. PubMed ID: 10321361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Physician Organization-Affiliated Political Action Committee Contributions With US House of Representatives and Senate Candidates' Stances on Firearm Regulation.
    Schuur JD; Decker H; Baker O
    JAMA Netw Open; 2019 Feb; 2(2):e187831. PubMed ID: 30794295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where there's smoke there's money: tobacco industry campaign contributions and U.S. Congressional voting.
    Luke DA; Krauss M
    Am J Prev Med; 2004 Dec; 27(5):363-72. PubMed ID: 15556735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the American Medical Association's campaign contributions influence health care legislation?
    Keiser KR; Jones W
    Med Care; 1986 Aug; 24(8):761-6. PubMed ID: 3736146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tobacco industry campaign contributions influencing state legislative behavior?
    Monardi F; Glantz SA
    Am J Public Health; 1998 Jun; 88(6):918-23. PubMed ID: 9618620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State legislators' perceptions of lobbyists and lobbying on tobacco control issues.
    Cohen JE; Goldstein AO; Flynn BS; Munger MC; Gottlieb NH; Solomon LJ; Dana GS
    Tob Control; 1997; 6(4):332-6. PubMed ID: 9583632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why the United States does not have a national health program: the medical-industry complex and its PAC contributions to congressional candidates, January 1, 1981, through June 30, 1991. Common Cause.
    Int J Health Serv; 1992; 22(4):619-44. PubMed ID: 1399173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unhealthy money: the growth in health PACs' congressional campaign contributions.
    Podhorzer M; Driscoll L; Rothschild ES
    Int J Health Serv; 1993; 23(1):81-93. PubMed ID: 8425791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of failed tobacco control legislation.
    Moore S; Wolfe SM; Lindes D; Douglas CE
    JAMA; 1994 Oct; 272(15):1171-5. PubMed ID: 7933346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco industry campaign contributions are affecting tobacco control policymaking in California.
    Glantz SA; Begay ME
    JAMA; 1994 Oct; 272(15):1176-82. PubMed ID: 7933347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Firearm Policy: Physician Organizations' Role in Political Action Committee Funds, 2018.
    Neufeld MY; Sanchez SE; Siegel M
    Am J Public Health; 2019 Nov; 109(11):1586-1588. PubMed ID: 31536396
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of Canadian legislators' support for tobacco control policies.
    Cohen JE; de Guia NA; Ashley MJ; Ferrence R; Northrup DA; Studlar DT
    Soc Sci Med; 2002 Sep; 55(6):1069-76. PubMed ID: 12220090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Term limits and the tobacco industry.
    Apollonio DE; Glantz SA; Bero LA
    Soc Sci Med; 2014 Mar; 104():1-5. PubMed ID: 24581055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As healthcare groups help fill campaign coffers, the question is: what is the money buying?
    Wagner L; Weissenstein E
    Mod Healthc; 1992 Nov; 22(44):38-40. PubMed ID: 10122168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of state legislators' intentions to vote for cigarette tax increases.
    Flynn BS; Goldstein AO; Solomon LJ; Bauman KE; Gottlieb NH; Cohen JE; Munger MC; Dana GS
    Prev Med; 1998; 27(2):157-65. PubMed ID: 9578987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bribery or just desserts? Evidence on the influence of Congressional reproductive policy voting patterns on PAC contributions from exogenous variation in the sex mix of legislator offspring.
    Conley D; McCabe BJ
    Soc Sci Res; 2012 Jan; 41(1):120-9. PubMed ID: 23017701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor activity is associated with US legislators' attention to political issues.
    Goel P; Malkin N; Gaynor SW; Jojic N; Miler K; Resnik P
    PLoS One; 2023; 18(9):e0291169. PubMed ID: 37729186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.